Josefine Freiberg

Josefine Freiberg serves as a Guest Researcher in the Department of Drug Design and Pharmacology within the Faculty of Health and Medical Sciences at the University of Copenhagen. Her work centers on translational clinical pharmacology with a specialized focus on glaucoma pathogenesis and diagnostic innovation through advanced retinal imaging techniques.

Education:

• MD, University of Copenhagen

Research Focus: Dr. Freiberg investigates retinal vessel morphology as a biomarker for glaucoma progression, develops automated image analysis protocols for retinal scans, and identifies early biomarkers for primary open-angle glaucoma. Her research leverages the large-scale FOREVER cohort (57,464 subjects) to explore ocular-systemic disease links, particularly between atopic dermatitis and ocular surface disease. She actively examines pharmaceutical safety profiles of artificial tears and preservatives in ophthalmic formulations.

Publication Trends: Recent work (2024-2025) demonstrates strong emphasis on glaucoma outcome measures, nongenetic risk factors, and ocular surface disease epidemiology. Her systematic reviews establish new methodological standards for clinical trials, while FOREVER cohort analyses reveal critical associations between vascular parameters and glaucoma progression. Collaborative publications span ophthalmology, dermatology, and pharmaceutical science journals.

Scientific Recognition:

• Best Young Investigator contribution (Glaucoma) - October 2, 2021

Dr. Freiberg contributes significantly to the FOREVER consortium's mission of optimizing predictive eye exam reliability in community optometry settings. Her translational approach bridges clinical observation with pharmaceutical science, particularly regarding preservative toxicity in ocular therapeutics.